GLP-1 receptor agonists include semaglutide (Wegovy) For some patients, metabolic and bariatric surgery may be an alternative to obesity pharmacologic treatment
Food frequency questionnaire (FFQ) Participants completed an online, graphical FFQ (VioScreen, Viocare Inc., Princeton, NJ, USA) assessing dietary intake over the 30 days preceding Phase I to estimate habitual L-carnitine consumption
Some people may experience stomach upset with higher doses
These patches are usually some concoction of vitamins, caffeine, or other substances, but they do not contain any actual GLP-1 medication
It has been available longer than tirzepatide, which means more post-market surveillance data exists for patients with thyroid conditions